Wells Fargo’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,800
Closed -$618K 7075
2024
Q3
$618K Buy
2,800
+400
+17% +$82.8K ﹤0.01% 3858
2024
Q2
$472K Hold
2,400
﹤0.01% 3950
2024
Q1
$517K Buy
+2,400
New +$504K ﹤0.01% 3867
2023
Q4
Sell
-42,500
Closed -$8.51M 7604
2023
Q3
$8.51M Hold
42,500
﹤0.01% 1679
2023
Q2
$7.87M Hold
42,500
﹤0.01% 1776
2023
Q1
$8.14M Buy
+42,500
New +$7.69M ﹤0.01% 1740
2022
Q1
Sell
-17,900
Closed -$4.09M 7132
2021
Q4
$4.09M Buy
+17,900
New +$3.94M ﹤0.01% 2780

Other funds holding CME

Wells Fargo's CME Position: Q2 2026 in Review

Wells Fargo reduced its CME Group (CME) stake by 3.2% in Q2 2026, selling an estimated $10.2M and leaving 1,099,691 shares worth $243M. The position accounts for 0.04% of the portfolio, ranked #370.

Wells Fargo first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $646M in Q1 2018. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Wells Fargo held 1,099,691 shares of CME Group worth $243M as of Q2 2026.
  • Wells Fargo sold 36,827 CME Group shares in Q2 2026, an estimated $10.2M.
  • CME Group made up 0.04% of Wells Fargo's portfolio in Q2 2026, its #370 holding.
  • Wells Fargo first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's CME Group position peaked at $646M in Q1 2018.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.